SPHERA FUNDS MANAGEMENT LTD's Q3 2026 13F: 20 new positions, 17 exits

Form 13F-HR for the quarter ended Sep 30, 2026 · filed Nov 16, 2026 · 100 reported positions · accession 0001496201-26-000006

What changed this quarter

SPHERA FUNDS MANAGEMENT LTD's changes in reported equity positions, Q3 2026
Activity Security Weight before Weight now Change Shares Shares %
Increased ALNYLAM PHARMACEUTICALS INC (ALNY) 0.5% 4.5% +4.0 pts +110K sh +1017%
New ISHARES TR (SOXX) — 3.2% +3.2 pts +37,000 sh new
Reduced CYBIN INC (CYBN) 1.5% 0.7% −0.8 pts −1.23M sh −76%
Exited INSMED INC (INSM) 1.8% — −1.8 pts −119K sh −100%
New META PLATFORMS INC (META) — 1.8% +1.8 pts +16,200 sh new
Increased CYTOKINETICS INC (CYTK) 2.7% 3.6% +0.9 pts +142K sh +65%
New KLA CORP (KLAC) — 1.3% +1.3 pts +45,220 sh new
Exited SOLAREDGE TECHNOLOGIES INC (SEDG 2.25 07/01/29) 1.1% — −1.1 pts −4M sh −100%
New ABIVAX SA (ABVX) — 1.1% +1.1 pts +73,716 sh new
New PHARVARIS N V (PHVS) — 1.1% +1.1 pts +230K sh new
New CAMTEK LTD (CAMT) — 1.1% +1.1 pts +46,800 sh new
Exited XENON PHARMACEUTICALS INC (XENE) 0.9% — −0.9 pts −105K sh −100%
Exited ZENAS BIOPHARMA INC (ZBIO) 0.8% — −0.8 pts −231K sh −100%
Reduced ORIC PHARMACEUTICALS INC (ORIC) 1.2% 0.7% −0.5 pts −404K sh −54%
Reduced TOWER SEMICONDUCTOR LTD (TSEM) 4.0% 2.9% −1.1 pts −23,525 sh −22%
Increased NOVA LTD (NVMI) 2.0% 2.3% +0.3 pts +13,875 sh +55%
New ANNEXON INC (ANNX) — 0.8% +0.8 pts +1.22M sh new
Increased IMMATICS N.V (IMTX) 1.0% 1.7% +0.7 pts +585K sh +81%
Exited FORTE BIOSCIENCES INC (FBRX) 0.8% — −0.8 pts −250K sh −100%
Reduced CELLDEX THERAPEUTICS INC NEW (CLDX) 1.3% 0.4% −0.8 pts −150K sh −62%
Reduced BIOGEN INC (BIIB) 3.0% 2.6% −0.4 pts −20,863 sh −22%
Increased FIRST TRACKS BIOTHERAPEUTICS (TRAX) 0.1% 0.9% +0.8 pts +132K sh +475%
Exited VISTRA CORP (VST) 0.7% — −0.7 pts −29,450 sh −100%
Exited TALEN ENERGY CORP (TLN) 0.7% — −0.7 pts −12,135 sh −100%
Increased BRIDGEBIO PHARMA INC (BBIO) 2.6% 3.1% +0.5 pts +66,371 sh +27%
New TECTONIC THERAPEUTIC INC (TECX) — 0.7% +0.7 pts +187K sh new
Increased MADRIGAL PHARMACEUTICALS INC (MDGL) 1.3% 2.0% +0.6 pts +8,376 sh +48%
Exited GLOBAL X FDS (CLOU) 0.6% — −0.6 pts −196K sh −100%
Increased TENAX THERAPEUTICS INC (TENX) 0.3% 0.7% +0.4 pts +2.2M sh +1827%
New CRESCENT BIOPHARMA INC. (CBIO) — 0.6% +0.6 pts +280K sh new
Exited BIOCRYST PHARMACEUTICALS INC (BCRX) 0.6% — −0.6 pts −422K sh −100%
Exited GENERATE BIOMEDICINES INC (GENB) 0.6% — −0.6 pts −245K sh −100%
New ADLAI NORTYE GROUP LTD (ANL) — 0.6% +0.6 pts +236K sh new
Reduced ULTRAGENYX PHARMACEUTICAL IN (RARE) 2.8% 0.8% −2.0 pts −250K sh −42%
Reduced MINERALYS THERAPEUTICS INC (MLYS) 5.7% 5.0% −0.6 pts −148K sh −10%
New Q32 BIO INC (QTTB) — 0.6% +0.6 pts +449K sh new
New RAPPORT THERAPEUTICS INC (RAPP) — 0.5% +0.5 pts +100K sh new
Increased DISC MEDICINE INC (IRON) 0.7% 1.1% +0.5 pts +51,200 sh +81%
New LATIGO BIOTHERAPEUTICS INC (LTGO) — 0.5% +0.5 pts +192K sh new
New APPLIED OPTOELECTRONICS INC (AAOI) — 0.5% +0.5 pts +32,210 sh new
Reduced HARMONY BIOSCIENCES HLDGS IN (HRMY) 0.9% 0.6% −0.4 pts −80,900 sh −46%
Reduced ACADIA PHARMACEUTICALS INC (ACAD) 1.3% 0.6% −0.7 pts −154K sh −43%
Increased EVOMMUNE INC (EVMN) 0.0% 0.5% +0.4 pts +368K sh +1626%
Exited KODIAK SCIENCES INC (KOD) 0.5% — −0.5 pts −81,796 sh −100%
Exited ORMAT TECHNOLOGIES INC (ORA) 0.4% — −0.4 pts −28,015 sh −100%
Increased LAM RESEARCH CORP (LRCX) 1.1% 1.3% +0.1 pts +7,430 sh +40%
Exited BIOHAVEN LTD (BHVN) 0.4% — −0.4 pts −164K sh −100%
Exited CONSTELLATION ENERGY CORP (CEG) 0.4% — −0.4 pts −9,850 sh −100%
Exited VERASTEM INC (VSTM) 0.3% — −0.3 pts −633K sh −100%
Reduced BIOMARIN PHARMACEUTICAL INC (BMRN) 2.7% 2.7% 0.0 pts −35,304 sh −11%

The 50 largest of 101 changes, by size of the trade. Full holdings for this quarter.

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:

  • CURIS INC (CRIS): 231269309 → 231269408, 98,996 → 39,665 shares (share count changed with the identifier; not shown as a trade)
  • TEVA PHARMACEUTICAL INDS LTD (TEVA): 881624209 → M8769Q102, 1.5M → 821K shares (share count changed with the identifier; not shown as a trade)

Top 10 positions — 35.4% of the equity book

Changes in the top 10 this quarter: ALNY entered · SOXX entered · RARE left · COGT left

# Security Weight before Weight now
1 MINERALYS THERAPEUTICS INC (MLYS) 5.7% 5.0%
2 TEVA PHARMACEUTICAL INDS LTD (TEVA) 7.3% 4.9%
3 ALNYLAM PHARMACEUTICALS INC (ALNY) 0.5% 4.5% Entered the top 10
4 CYTOKINETICS INC (CYTK) 2.7% 3.6%
5 ISHARES TR (SOXX) 0.0% 3.2% Entered the top 10
6 BRIDGEBIO PHARMA INC (BBIO) 2.6% 3.1%
7 TOWER SEMICONDUCTOR LTD (TSEM) 4.0% 2.9%
8 SYNDAX PHARMACEUTICALS INC (SNDX) 3.2% 2.9%
9 BIOMARIN PHARMACEUTICAL INC (BMRN) 2.7% 2.7%
10 BIOGEN INC (BIIB) 3.0% 2.6%
— ULTRAGENYX PHARMACEUTICAL IN (RARE) 2.8% 0.8% Left the top 10
— COGENT BIOSCIENCES INC (COGT) 2.5% 2.4% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Exited BIOGEN INC (BIIB) Call 100K 0 $0
Reduced SPDR SERIES TRUST (XBI) Put 150K 75,000 $11.8M
New ARK ETF TR (ARKG) Put 0 200K $10.8M
Exited CYTOKINETICS INC (CYTK) Call 100K 0 $0
Exited ISHARES TR (TLT) Call 47,000 0 $0
New CYBIN INC (CYBN) Call 0 300K $3.69M
New TREVI THERAPEUTICS INC (TRVI) Call 0 250K $3.58M
New RAPPORT THERAPEUTICS INC (RAPP) Put 0 100K $3.36M
New CELLDEX THERAPEUTICS INC NEW (CLDX) Put 0 100K $3.24M
Exited ABIVAX SA (ABVX) Put 20,000 0 $0
New TECTONIC THERAPEUTIC INC (TECX) Call 0 100K $2.33M
New SYNDAX PHARMACEUTICALS INC (SNDX) Call 0 100K $1.88M
Exited ORIC PHARMACEUTICALS INC (ORIC) Call 100K 0 $0
New ANNEXON INC (ANNX) Put 0 250K $1.06M
New ANNEXON INC (ANNX) Call 0 250K $1.06M
New DISC MEDICINE INC (IRON) Call 0 50,000 $335K